Brian Dawes, MD, PhD

Brian earned his undergraduate degree in molecular and cellular biology at the University of Illinois and his MD/PhD at the University of Texas Medical Branch. He completed his PhD research in the Galveston National Lab with extensive training in biosafety and biocontainment while working in high containment BSL3 and BSL4 labs. His dissertation research studied the effects of emerging encephalitic viruses on neural cells and how the immune responses in these cells affects viral replication.  He also assessed the use of the antiviral compound favipiravir against Nipah virus.  In addition to his research, Brian has contributed to Nipah virus and Zika virus vaccine development pipeline analyses for the WHO.  He remains committed to studying emerging viruses and developing effective countermeasures such as vaccines and antivirals.  He is especially interested in working with populations directly affected by these diseases and ensuring equitable, ethical, and timely access to approved and experimental countermeasures. During residency, he studied the epidemiology of Rift Valley Fever virus under the mentorship of Dr. Desiree LaBeaud, and attitudes toward vaccination to Nipah virus in endemic areas under the mentorship of Dr. Stephen Luby.

Andrew Enslen, MD

Andrew completed his undergraduate years at Pepperdine University and his medical school training at UCSD. As a medical student, he earned an MPH from Harvard, focusing on Quantitative Methods and with a concentration in Epidemiology and Infectious Diseases. During his MPH year, he evaluated modifiable factors associated with infant death in Lusaka, Zambia and he assessed whether entomological surveys served as a useful tool to anticipate dengue outbreaks in Brazil. During his residency, he pursued opportunities to develop his passion for medical education in resource-limited settings. Specifically, during his junior year, he spent 4 weeks teaching at the bedside at the Centre Hospitalier de Kigali (Rwanda), and during his senior year, he returned to Rwanda and spent 7 weeks doing curriculum development, lecturing and teaching on the wards for medical students at the University of Global Health Equity in Butaro, Rwanda.

Andrew Young Chang, MD, MS

ECHOCARDIOGRAPHY FELLOW, UCSF

During medical school, Dr. Chang co-founded a social venture to develop a low-cost ventilatory support device for neonatal respiratory distress in resource-limited countries. During residency, he became interested in cardiology and subsequently conducted epidemiologic and qualitative research in women of reproductive age living with rheumatic heart disease in Uganda. After a Chief Resident year, he continued his training at Stanford as a Cardiology fellow, and earned a Master’s Degree and ultimately his Ph.D. in Epidemiology and Clinical Research.  Dr. Chang’s interests include outcomes research, implementation science, and health systems modeling to combat the rise of cardiovascular disease in low- and middle-income countries. After completing his training, he worked as a cardiology attending at the Palo Alto VA prior deciding to pursue additional training, where he is currently studying echocardiography at UCSF.

MEDICAL OFFICER, CENTERS FOR DISEASE CONTROL AND PREVENTION, DENGUE BRANCH, PUERTO RICO

Before starting his medical career, Dr. Wong worked with the CDC for 2 years in Nairobi, Kenya. As a medical student, he worked in South Africa, and during his residency, he provided clinical service and teaching in Cali, Colombia and Kampala, Uganda. Josh’s past experience with the CDC evolved into a passion for working in global health on a systems level. Following residency, he began his career as an Epidemiology Intelligence Officer for the CDC, which then evolved into his current permanent position as Medical Officer within the CDC Dengue Branch in Puerto Rico.

Yoanna Pumpalova, MD

GASTROINTESTINAL ONCOLOGIST I COLUMBIA UNIVERSITY

Yoanna’s interest in global health began when she worked in a clinic whose mission is to provide affordable and reliable cervical cancer screening to indigenous women in rural Peru. During her global health residency, she further defined her interest in global oncology, and she worked in Uganda during both her second and third years, studying prognostic awareness amongst women with metastatic breast cancer undergoing palliative chemotherapy. She completed her Hematology-Oncology fellowship at Columbia University, where she is now on the Oncology faculty. Her current research focuses on the diagnosis, treatment, and prevention of colorectal cancer in low- and middle-income countries, namely South Africa and the Dominican Republic.